Prescription medications should never feel out of reach. Yet for many Americans, the cost of medications remains one of the biggest barriers to staying healthy. High deductibles, rising drug prices, and gaps in insurance coverage can force patients to delay refills, skip doses, or go without the treatments they need altogether. Ensuring medications remain affordable is essential to improving health outcomes and supporting healthier communities. At OneroRx, we understand that

West Des Moines, IA — April X, 2026 — OneroRx, a community-focused healthcare provider, announced the immediate availability of Brenzavvy (bexagliflozin), a lower-cost SGLT2 inhibitor for adults with type 2 diabetes. Approved by the FDA in 2023 and developed by TheracosBio, Brenzavvy helps improve blood glucose control while addressing a major barrier to care: affordability. As one of the most cost-effective options in its class, it aims to support better adherence and long-t

FOR IMMEDIATE RELEASE May 19, 2026 — OneroRX today announced the appointment of Dr. Rinku Patel and Daniel Varnum to its Board of Directors, as it continues to expand its impact in healthcare innovation and pharmacy solutions. Dr. Patel brings extensive leadership experience in healthcare strategy, operations, and growth initiatives. Her expertise will support OneroRx’s continued focus on delivering patient-centered pharmacy services and scalable healthcare solutions. Mr.

The purchase includes 14 NuCara Retail Pharmacies and 10 NuCara Home Medical stores. WEST DES MOINES, IA, April 2, 2026 — OneroRx, an integrated pharmacy serving underserved markets, has completed its acquisition of 14 NuCara Pharmacy and 10 Home Medical Equipment locations in Iowa and Minnesota, bringing its total to 91 locations across eight Midwest states, employing over 1,000 team members. OneroRx operates as the largest franchisee of the Medicap Pharmacy brand owned by C

West Des Moines, IA — June 1, 2026 — OneroRx, a community-focused healthcare provider, announced the immediate availability of Brenzavvy (Bexagliflozin), a lower-cost SGLT2 inhibitor for adults with type 2 diabetes. Approved by the FDA in 2023 and developed by TheracosBio, Brenzavvy helps improve blood glucose control while addressing a major barrier to care: affordability. As one of the most cost-effective options in its class, it aims to support better adherence and long-te

Two LTC Pharmacies will operate as Medicap LTC West Des Moines, IA, April 10, 2026 – OneroRx proudly announces the acquisition of two NuCara Long-Term-Care pharmacies, in Iowa City, IA and Waterloo, IA. The addition signifies continued expansion of specialized pharmacy services tailored for long-term care facilities. This announcement follows the recent purchase of 14 retail pharmacies and 10 home medical supply stores. This brings the total number of OneroRx locations to 9

OneroRx is proud to announce the appointment of Amy Mitchell as President, marking an new chapter in the company’s growth and leadership. Joseph Dunham will continue his role as Chairman and Chief Executive Officer at OneroRx. Mitchell's promotion will enable Dunham to further expand strategic initiatives at OneroRx. This appointment ensures business continuity and further develops the organizations talent pipeline. “I am truly honored to be named as President at OneroRx. My

It has come to our attention that some Iowa companies recently communicated with its employees regarding Senate File 383 (SF 383), the...